To clarify the role of PI3K/AKT/mTOR signaling in the regulation of multiple myeloma cell proliferation and apoptosis by CIP2A, we evaluated the effect of IGF-1 which could activate PI3K [14] on RPMI-8226 and NCI-H929 cells. The gene discussed is AKT1; the disease is plasma cell myeloma.